Ozanimod, Ozanimod
RPC01-3204
Phase 3 small_molecule active
Quick answer
Ozanimod, Ozanimod for Moderately to Severely Active Crohn's Disease is a Phase 3 program (small_molecule) at Celgene Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Celgene Europe Limited
- Indication
- Moderately to Severely Active Crohn's Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active